{
  "ptid_time": "009_S_0842_2014-10-14",
  "img_path": "/data/qiuhui/data/adni/images/009_S_0842/2014-10-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 48,069 mm³, 2.2% above the reference mean. With a Z-score of 0.07 (52.6th percentile), this represents normal volume ; hippocampal volume measures 6,323 mm³, 9.3% below the reference mean. With a Z-score of -0.80 (21.2th percentile), this represents normal volume ; whole brain volume measures 1,118,900 mm³, 8.7% above the reference mean. With a Z-score of 1.14 (87.3th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,707 mm³, 6.6% below the reference mean. With a Z-score of -0.43 (33.3th percentile), this represents normal volume ; fusiform gyrus volume measures 21,152 mm³, 17.1% above the reference mean. With a Z-score of 1.48 (93.0th percentile), this represents mild enlargement; middle temporal gyrus volume measures 23,900 mm³, 18.5% above the reference mean. With a Z-score of 1.66 (95.1th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 81.6 years. Gender is Male. Education: 18 years. MMSE: 30.0. MoCA: 26.0. Logical Memory: 10.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.53 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is slightly reduced (9.3% below mean, Z-score -0.80), but still within the normal range. The MMSE is intact (30/30), but the MoCA (26/30) suggests mild cognitive inefficiency, possibly due to age or early MCI. The AV45 (amyloid PET) shows profound elevation, indicating significant amyloid pathology, which is concerning for Alzheimer’s disease (AD) risk despite normal cognitive scores.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, preclinical AD trajectory)  \n**Confidence:** **Medium** (cognitive scores are borderline, but amyloid burden strongly suggests early AD pathology)",
  "timestamp": "2025-07-25T22:13:19.026285"
}